Try our Advanced Search for more refined results
Life Sciences - January, 2009
146 articles
- GSK Records $400M Legal Charge In Off-Label Probe
- BASF Told To Pay Insurers $1.7M In Synthroid Suit
- EPA Extends Comment Period On Drug Waste Rule
- Judge Refuses To Dismiss Lexapro Declaratory Action
- Pfizer Garners Win In Viagra MDL Discovery Spat
- 2nd Circ. Revives Nigerian Families' Case V. Pfizer
- Lilly Officially Pleads Guilty In Zyprexa Debacle
- Divestiture Paves Way For Getinge, Datascope Merger
- CB Fleet, 7 Plaintiffs Settle Bowel Cleanser Suits
- High Court Asked To Weigh Inequitable Conduct Ruling
- Democrats Unveil Revised Import Safety Bill
- Discovery To Proceed In NFL StarCaps Suit: Judge
- Nearly 250 Mirapex Plaintiffs Settle In MDL
- Fed. Circ. Braces For Overhaul As Retirements Loom
- Lilly Sues Invagen Over Osteoporosis Drug Evista
- Third-Party Enforcement For Counterfeiting
- 2nd Circ. Tosses Securities Suit Over Bextra, Celebrex
- Post-EBay: Permanent Injunctions, Future Damages
- Judge Sets Deadline For Prempro MDL Discovery
- FDA Warns Of Addictive Drug In Bodybuilding Pills
- Crowell Hires Former FDA Official As Consultant
- Judge Tosses 2 Cases In Seroquel MDL
- Troubled KV Issues Near-Total Recall
- Medtronic, BSC Agree To Halt 5 Patent Spats
- Invention Incentive Programs Get Results: Survey
- Senate Judiciary Committee OKs Holder In 17-2 Vote
- Supreme Court Asked To Weigh In On Bilski Case
- Is Your Application Ready Under KSR?
- Aventis Files Another Patent Suit Over Allegra
- Caraco Hits Forest Over 3rd Lexapro Patent
- Pfizer To Pay $2.3B In Bextra Off-Label Marketing Suit
- P&G, Roche Sue Sun Over Generic Actonel ANDA
- Baxter Sues Rival Over Anesthetic Container Patent
- FDA's Protection Powers 'Hampered': GAO
- FDA, Drug Cos. To Review Blood Thinner Plavix
- Caliper Sues Shimadzu Over DNA Research Patents
- The Rise In Litigation From FCPA Enforcement
- Court Asks Parties For Input In Medtronic MDL
- Economic Analysis In Off-Label Promotion Cases
- Minn. High Court To Mull Negligence-Claim Time Limit
- Cordis Loses Bid For More Discovery In Patent Suit
- Pfizer, Wyeth Merger May Test Obama FTC's Mettle
- India Plans Overhaul Of Patent Application System
- Elan Sues Alcon Over Eye Treatment Azopt
- P&G, Sanofi's Actonel Dragged Into Fosamax MDL
- Revisions To The AdvaMed Code Of Ethics
- Most Claims Survive In US Bioservices IP Suit
- Calif. Supreme Court Declines To Hear Conte Case
- Insurers To Reduce Liens On Vioxx Settlement Awards
- Former USPTO Judge Leaves Venable For Proskauer
- Conte V. Wyeth Spotlights 'Pioneer Liability' Claims
- Womble Carlyle Expands Life Sciences Patent Unit
- 2 Of King's Skelaxin Patents Invalidated
- Novel Hits Back With Antitrust Charges In Patent Suit
- Medical Groups Dismissed From Prempro MDL
- Account Exec Cut From RICO Suit Against CMH
- ANDAs Must Include All Bioequivalence Data: FDA
- House Panel To Mull BPA Ban In Baby Products
- Judge Tosses Kickback Suit Against Stryker
- IP Joint Ownership Creates Challenges For Cos.
- Travelers Units Deny Heparin Claims Obligations
- M&A Practice: White & Case
- Merck Strikes Teva With 3rd Singulair Suit
- Warner Chilcott Brings New Patent Suit Over Doryx
- New Mass. Patent Rules A Boon After TS Tech
- AstraZeneca Fires Off New Suit Over Nexium Patents
- SEC Slaps Medical Supply Cos., CEO With Fraud Suit
- 3 Reasons NJ May Be New IP Venue Of Choice
- Judge Blasts Centocor Bid In Humira Patent Case
- Andrx, Sciele Sue Lupin Over Diabetes Drug ANDA
- Surgery Toolmakers Settle Drill Guide Suit
- Judge Slams 'Boilerplate' Prempro Claims
- Covidien Settles With Rochester Medical For $3.5M
- Novartis Beats Sales Reps' Wage-And-Hour Suit
- Oscient Files Patent Suit Over Cholesterol Drug
- IP Practice: Dechert
- Taiwan HIV Hemophiliac Cases Head Back To Calif.
- FDA Releases New Safety Guidelines
- Former NFL Player Sues Plan Over Disability Benefits
- GAO Tells FDA To Toughen Class III Device Review
- $1.4B Zyprexa Deal Could Spark More Qui Tam Suits
- Plaintiffs' Experts In '08 Securities Class Actions
- Fed. Circ. Finds Boston Scientific Patent Invalid
- FDA Unveils Final Rules On Engineered Animals
- Judge OKs $20M DIP Financing For Equal Maker
- Wyeth, Pfizer Push To Get Prempro MDL Tossed
- Mylan, Barr, Sandoz Sued Over ANDAs For Solodyn
- 9th Circ. Revives Hytrin Saga
- Lilly Set To Hand Over $1.4B Zyprexa Payout: Report
- Indevus Investors Sue To Halt Endo Merger
- Infringement Claims Nixed In Focalin Patent Suits
- Law Firm In Foltx Patent Suit Not In Conflict: Judge
- FDA Appoints 2 To Bolster Global Programs, IT
- Pioneer Liability After Conte V. Wyeth
- QLT Could Pay Mass. Hospital $113M In Visudyne Case
- AstraZeneca Slaps Biovail Over Seroquel XR
- Preemption: Coming To A Court Near You In 2009
- Judge Looks To Wipe Out Medtronic MDL
- FDA OKs Journal Articles Promoting Off-Label Uses
- Sanofi Slaps Novo Nordisk Over Safety Needle Patent
- HHS Slams FDA Over Conflict-Of-Interest Monitoring
- Equal Maker Seeks Access To $20M In DIP Cash
- Warner Chilcott, Watson Settle Birth Control Dispute
- Sidley Life Sciences Duo Jump To Baker Botts
- Alcon Itches For Fight Over Allergy Eyedrops Patent
- Citing KSR, Fed. Circ. Dismisses Suit V. RealNetworks
- Trial Lawyers Call For Preemption Overhaul
- Illegal Diet Pills Pose Serious Risks, FDA Warns
- US Ignores Link Between Vaccines, Autism: Suit
- CoreValve Beats Edwards' Infringement Suit In UK
- Business Not So Sweet As Equal Maker Enters Ch. 11
- Drug Industry Critic Tapped For FDA Seat
- Alzheimer's Patients Could Die From Risperdal: Study
- Investor Sues Medtronic Over Alleged Infuse Scheme
- Pa. Presses To Wage Vioxx Battle On State Turf
- Galderma Sues Paddock Over Clobex ANDA
- Wyeth Hits Another Generics Maker Over Effexor XR
- An Eye On Revising The FCA
- Zicam Cold Remedy Took User's Sense Of Smell: Suit
- Suit Targets Impax's Move To Sell Generic Amrix
- FDA Finds More Chemical Traces In Baby Formula
- FDA Eyed Over $1.5M Consulting Contract
- Claims Over Drugs Used To Make Meth May Yet Fly
- Breckenridge Challenges Everett's Vitamin Patents
- Fed. Circ. Hears Arguments In Kubin Biotech Case
- Roche Drops Patent From Suits Over Generic Boniva
- Bradley Pharma Settles Securities Suit For $3.5M
- $100M Superfund Settlement Propels NJ Cleanup
- Dey LP Strikes $5M Deal In State Court AWP Case
- The CBO's Take On Health Care Reform
- Canada Issues Renewed Warning Over Chantix
- Becton Dickinson To Settle UltiMed Antitrust Suit
- Schering Faces Antitrust Suit Over Albuterol Prices
- Judge Tosses Medtronic MDL On Preemption Grounds
- Plaintiffs Seek Lift Of Stay In McKesson Antitrust Suits
- Drug Cos. Not Liable For Meds Used In Meth: 8th Circ.
- Abbott Strikes Back At Bayer Patent Suit Over Humira
- Teva, Mass. Settle Drug Price-Fixing Suit For $7M
- Raising The Bar For Securities Fraud Complaints
- Pozen Sues Alphapharm, Mylan Over Generic Treximet
- Samsung, Radio Shack Sued Over Cable Patent
- Merck's Fosamax May Boost Cancer Risk: FDA Official
- FDA Issues Guidance On OTC Drug Labeling Rules
- J&J Sales Rep Exempt From OT Under FLSA: Judge
- Alexion To Pay $25M To Settle Soliris Suit
- Strategies In The War Against Obviousness